Literature DB >> 16553874

Antibiotics and the ribosome.

Tanel Tenson1, Alexander Mankin.   

Abstract

The ribosome is one of the main antibiotic targets in the cell. Recent years brought important insights into the mode of interaction of antibiotics with the ribosome and mechanisms of antibiotic action. Ribosome crystallography provided a detailed view of the interactions between antibiotics and rRNA. Advances in biochemical techniques let us better understand how the binding of small organic molecules can interfere with functions of an enzyme four orders of magnitude larger than the inhibitor. These and other achievements paved the way for the development of new ribosome-targeting antibiotics, some of which have already entered medical practice. The recent progress, problems and new directions of research of ribosome-targeting antibiotics are discussed in this review.

Mesh:

Substances:

Year:  2006        PMID: 16553874     DOI: 10.1111/j.1365-2958.2006.05063.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  63 in total

1.  Nucleotide modifications and tRNA anticodon-mRNA codon interactions on the ribosome.

Authors:  Olof Allnér; Lennart Nilsson
Journal:  RNA       Date:  2011-10-25       Impact factor: 4.942

2.  RNAcentral: A vision for an international database of RNA sequences.

Authors:  Alex Bateman; Shipra Agrawal; Ewan Birney; Elspeth A Bruford; Janusz M Bujnicki; Guy Cochrane; James R Cole; Marcel E Dinger; Anton J Enright; Paul P Gardner; Daniel Gautheret; Sam Griffiths-Jones; Jen Harrow; Javier Herrero; Ian H Holmes; Hsien-Da Huang; Krystyna A Kelly; Paul Kersey; Ana Kozomara; Todd M Lowe; Manja Marz; Simon Moxon; Kim D Pruitt; Tore Samuelsson; Peter F Stadler; Albert J Vilella; Jan-Hinnerk Vogel; Kelly P Williams; Mathew W Wright; Christian Zwieb
Journal:  RNA       Date:  2011-09-22       Impact factor: 4.942

3.  Chloramphenicol acetyltransferase as selectable marker for plastid transformation.

Authors:  Weimin Li; Stephanie Ruf; Ralph Bock
Journal:  Plant Mol Biol       Date:  2010-08-19       Impact factor: 4.076

4.  Synergy between efflux pump CmeABC and modifications in ribosomal proteins L4 and L22 in conferring macrolide resistance in Campylobacter jejuni and Campylobacter coli.

Authors:  Cédric Cagliero; Christian Mouline; Axel Cloeckaert; Sophie Payot
Journal:  Antimicrob Agents Chemother       Date:  2006-08-28       Impact factor: 5.191

5.  Identifying and validating small molecules interacting with RNA (SMIRNAs).

Authors:  Matthew D Disney; Sai Pradeep Velagapudi; Yue Li; Matthew G Costales; Jessica L Childs-Disney
Journal:  Methods Enzymol       Date:  2019-05-15       Impact factor: 1.600

6.  Transcriptional and translational control of the mlr operon, which confers resistance to seven classes of protein synthesis inhibitors.

Authors:  Lisa K Smith; Alexander S Mankin
Journal:  Antimicrob Agents Chemother       Date:  2008-02-25       Impact factor: 5.191

7.  A novel insertion mutation in Streptomyces coelicolor ribosomal S12 protein results in paromomycin resistance and antibiotic overproduction.

Authors:  Guojun Wang; Takashi Inaoka; Susumu Okamoto; Kozo Ochi
Journal:  Antimicrob Agents Chemother       Date:  2008-12-22       Impact factor: 5.191

Review 8.  Large facilities and the evolving ribosome, the cellular machine for genetic-code translation.

Authors:  Ada Yonath
Journal:  J R Soc Interface       Date:  2009-08-05       Impact factor: 4.118

9.  Two-dimensional combinatorial screening identifies specific 6'-acylated kanamycin A- and 6'-acylated neamine-RNA hairpin interactions.

Authors:  Olga Aminova; Dustin J Paul; Jessica L Childs-Disney; Matthew D Disney
Journal:  Biochemistry       Date:  2008-12-02       Impact factor: 3.162

10.  Allosteric control of the ribosome by small-molecule antibiotics.

Authors:  Leyi Wang; Arto Pulk; Michael R Wasserman; Michael B Feldman; Roger B Altman; Jamie H Doudna Cate; Scott C Blanchard
Journal:  Nat Struct Mol Biol       Date:  2012-08-19       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.